Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01605071 · ClinicalTrials.gov registry record · NA

Timing Estrogen After MenoPaUSe

A NA study of Insulin Resistance, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT01605071 is a NA study of Insulin Resistance that has completed, run by University of Colorado, Denver. The registered enrollment target is 53 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01605071, a NA study of Insulin Resistance, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

The aim of the current study is to test whether the effect of estrogen on insulin metabolism depends on the timing of treatment relative to when a woman went through menopause. The investigators hypothesize that estrogen will improve insulin sensitivity in early postmenopausal women, but decrease insulin sensitivity in late postmenopausal women.

Conditions Studied

Interventions

  • DRUG Estradiol

Study Locations (1)

Colorado

  • University of Colorado Denver - Aurora

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2011-09
Est. Completion 2017-01
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT01605071

The ClinicalTrials.gov registry entry for NCT01605071 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (78% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Estradiol is the first listed.

NCT01605071 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT01605071 about?

NCT01605071 is a clinical study titled "Timing Estrogen After MenoPaUSe". The aim of the current study is to test whether the effect of estrogen on insulin metabolism depends on the timing of treatment relative to when a woman went through menopause. The investigators hypothesize that estrogen will improve insulin sensitivity in early postmenopausal women, but decrease in...

What is the current status of trial NCT01605071?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2011-09. Estimated completion is 2017-01.

What conditions does trial NCT01605071 study?

This clinical trial studies the following conditions: Insulin Resistance.

What interventions are being tested in trial NCT01605071?

The interventions under investigation include: Estradiol (DRUG).

Who is sponsoring clinical trial NCT01605071?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01605071 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.